What is Acotec Scientific Holdings Operating Cash Flow per Share?
Acotec Scientific Holdings's operating cash flow per share for the
six
months ended in Dec. 2023 was HK$-0.08.
Acotec Scientific Holdings's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.05.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -12.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Acotec Scientific Holdings's Operating Cash Flow per Share or its related term are showing as below:
HKSE:06669'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -12.5 Med: -12.5 Max: -12.5
Current: -12.5
During the past 5 years, Acotec Scientific Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was -12.50% per year. The lowest was -12.50% per year. And the median was -12.50% per year.
HKSE:06669's 3-Year OCF Growth Rate is ranked worse than 69.91% of 688
companies
in the Medical Devices & Instruments industry
Industry Median: 2.85
vs HKSE:06669: -12.50
Acotec Scientific Holdings Operating Cash Flow per Share Historical Data
The historical data trend for Acotec Scientific Holdings's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Acotec Scientific Holdings Operating Cash Flow per Share Chart
Competitive Comparison of Acotec Scientific Holdings's Operating Cash Flow per Share
For the Medical Devices subindustry, Acotec Scientific Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acotec Scientific Holdings's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Acotec Scientific Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Acotec Scientific Holdings's Price-to-Operating-Cash-Flow falls into.
Acotec Scientific Holdings Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Acotec Scientific Holdings's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.05
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acotec Scientific Holdings Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Acotec Scientific Holdings's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Acotec Scientific Holdings (HKSE:06669) Business Description
Acotec Scientific Holdings Ltd is a medical device company. The company is focused on providing leave nothing behind treatment solutions for vascular diseases. It has developed a suite of interventional medical devices featuring world- leading technologies, notably in the fields of drug-coated balloons and thrombus aspiration catheters. The company's commercialized product is Semi-compliant PTCA Balloon (YAN) is a product designed for dilation in coronary artery or coronary artery bypass vessels stenosis to improve myocardial perfusion. Geographically, the company operates from Mainland China, Europe and Other countries and regions. Majority of revenue is generated from Mainland China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06669 has been successfully added to your 